Semin intervent Radiol 2001; 18(4): 431-436
DOI: 10.1055/s-2001-19105
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Legal Considerations with Contrast Agent Use

Michael A. Bettmann, David B. Spring
  • Dartmouth-Hitchcock Medical Center, Department of Radiology, Lebanon, New Hampshire
Further Information

Publication History

Publication Date:
18 December 2001 (online)

ABSTRACT

Categories and considerations for a radiologist involved with intravenous contrast are defined in this article.

REFERENCES

  • 1 Bettmann M A, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry.  Radiology . 1997;  203 611-620
  • 2 Katayama H, Yamaguchi K, Kozuha T. Adverse reactions to ionic and nonionic contrast media.  Radiology . 1990;  175 621-628
  • 3 Spring D, Bettmann M A, Barkan, H E. Near fatal adverse reactions to iodinated contrast media: spontaneous reporting to the U.S. Food and Drug Administration, 1978-1994.  Radiology . 1997;  204 325-332
  • 4 Barloon T J, Shumway J M, Warnock M B. An approach to radiologic quality assurance: an analysis of medicolegal claims involving radiologic contrast media induced injury.  Acad Radiol . 1995;  2 1002-1004
  • 5 Bettmann M A, Holzer J F, Trombley S T. Risk management issues related to contrast agents.  Radiology . 1990;  175 629-631
  • 6 Jacobson P O, Rosenquist C J. The use of low osmolar contrast agents: technological change and defensive medicine.  J Health Politics, Policy and Law . 1996;  21 244-265
  • 7 Bush Jr H W. Risk factors, prophylaxis and therapy of x-ray contrast media reactions.  Adv X-ray Contrast . 1996;  3 44-53
    >